{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:31:20Z","timestamp":1787005880782,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.atherosclerosis.2019.04.218","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T12:20:07Z","timestamp":1554985207000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage"],"prefix":"10.1016","volume":"285","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4777-6300","authenticated-orcid":false,"given":"Carlo","family":"Cervellati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-7052","authenticated-orcid":false,"given":"Giovanni Battista","family":"Vigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Trentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana M.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6665-263X","authenticated-orcid":false,"given":"Francesca","family":"Zimetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Dalla Nora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6864-0547","authenticated-orcid":false,"given":"Mario Luca","family":"Morieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8462-7000","authenticated-orcid":false,"given":"Angelina","family":"Passaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med."},{"issue":"Suppl","key":"10.1016\/j.atherosclerosis.2019.04.218_bib2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/0021-9150(96)05852-2","article-title":"High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport","volume":"124","author":"Assmann","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib3","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1210\/jc.2011-1846","article-title":"LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals","volume":"97","author":"Haase","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.166.7.743","article-title":"Gemfibrozil in the treatment of dyslipidemia: an 18-year mortality follow-up of the Helsinki Heart Study","author":"Tenkanen","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib5","article-title":"Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the bezafibrate infarction prevention (BIP) study","author":"Behar","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2016.05.036","article-title":"Paraoxonases-1, -2 and -3: what are their functions?","volume":"259","author":"Furlong","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib7","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib8","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/ATVBAHA.112.300133","article-title":"High-density lipoprotein function, dysfunction, and reverse cholesterol transport","volume":"32","author":"Fisher","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib10","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2004.10.028","article-title":"Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine","volume":"179","author":"Rosenblat","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0006-2952(03)00401-5","article-title":"Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3","volume":"66","author":"Teiber","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","article-title":"Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles","volume":"567","author":"Mackness","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173385","article-title":"Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport","volume":"12","author":"Ikhlef","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clinbiochem.2008.09.120","article-title":"The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment","volume":"42","author":"Marsillach","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cca.2008.12.019","article-title":"Validation of PON1 enzyme activity assays for longitudinal studies","volume":"402","author":"Huen","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hq0901.094247","article-title":"Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?","volume":"21","author":"Mackness","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1515\/cclm-2014-0803","article-title":"PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia","volume":"53","author":"Cervellati","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2007.11.018","article-title":"Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women","volume":"199","author":"van Himbergen","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jnc.13240","article-title":"Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: a pilot study","volume":"135","author":"Cervellati","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.biocel.2016.06.008","article-title":"Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases","volume":"81","author":"Castellazzi","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.atherosclerosis.2008.08.031","article-title":"Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia","volume":"204","author":"Cefal\u00f9","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.mol.0000162318.47172.ef","article-title":"Inherited disorders of HDL metabolism and atherosclerosis","volume":"16","author":"Hovingh","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.numecd.2014.02.010","article-title":"Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia","volume":"24","author":"Vigna","year":"2014","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5694058","article-title":"Lactonase activity and lipoprotein-phospholipase A2as possible novel serum biomarkers for the differential diagnosis of autism spectrum disorders and rett syndrome: results from a pilot study","volume":"2017","author":"Hayek","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/138920112799095383","article-title":"Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerations","volume":"13","author":"Zanotti","year":"2012","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2009.01.006","article-title":"A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred","volume":"205","author":"Calabresi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib30","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1373\/clinchem.2004.034439","article-title":"Distribution spectrum of paraoxonase activity in HDL fractions","volume":"50","author":"Bergmeier","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib31","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nsmb767","article-title":"Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes","volume":"11","author":"Harel","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2005.08.026","article-title":"Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes","volume":"187","author":"Rosenblat","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib34","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.freeradbiomed.2012.01.019","article-title":"Purified human paraoxonase-1 interacts with plasma membrane lipid rafts and mediates cholesterol efflux from macrophages","volume":"52","author":"Berrougui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib35","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/eurheartj\/ehy169","article-title":"Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease","volume":"39","author":"Helgadottir","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2008.03.023","article-title":"Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues","author":"Marsillach","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib37","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/1873-3468.12198","article-title":"Paraoxonase 1-treated oxLDL promotes cholesterol efflux from macrophages by stimulating the PPAR\u03b3-LXR\u03b1-ABCA1 pathway","volume":"590","author":"Ikhlef","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/ATVBAHA.108.179283","article-title":"Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib39","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1161\/CIRCRESAHA.114.303974","article-title":"Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified","volume":"114","author":"Javaheri","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib40","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/01.ATV.19.9.2214","article-title":"Human serum Paraoxonase\/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids\u202f: apolipoprotein A-I stabilizes activity","volume":"19","author":"Sorenson","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib41","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.38118","article-title":"Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis","volume":"65","author":"Charles-Schoeman","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pjnns.2016.07.002","article-title":"The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients","volume":"50","author":"Arslan","year":"2016","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib43","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.1073\/pnas.0802025105","article-title":"Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I","volume":"105","author":"Shao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib44","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/CIRCRESAHA.114.303454","article-title":"Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase","volume":"114","author":"Shao","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/jhh.2010.10","article-title":"Relationship between paraoxonase-1 activity, carotid intima-media thickness and arterial stiffness in hypertensive patients","volume":"24","author":"Yang","year":"2010","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib46","first-page":"1","article-title":"Association of carotid intima media thickness with atherogenic index of plasma, apo B\/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease","author":"Fadaei","year":"2018","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000112322","article-title":"Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease","volume":"25","author":"Harangi","year":"2008","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/ene.12074","article-title":"Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities","volume":"20","author":"Shenhar-Tsarfaty","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cca.2014.09.016","article-title":"Paraoxonase 1 and HDL maturation","volume":"439","author":"Gugliucci","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.04.218_bib50","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1001\/jama.299.23.2777","article-title":"Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk","volume":"299","author":"Thompson","year":"2008","journal-title":"J. Am. Med. Assoc."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019303843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019303843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:38:23Z","timestamp":1758155903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019303843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":50,"alternative-id":["S0021915019303843"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.04.218","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.04.218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}